Welcome to the PharmCast Research Store. Gain access to market leading research in your industry. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (29)

5,000 - 9,999 (56)

10,000 - 49,999 (113)

50,000+ (40)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (20)

500 - 999 (11)

1,000 - 1,999 (45)

2,000+ (189)

Top stories

Taisho announces encouraging results from Phase III osteoarthritis trials

Taisho Pharmaceutical Co., Ltd. has announced encouraging results from two Phase III clinical trials with the anti-inflammatory analgesic patch formulation containing S-flurbiprofen, or TT-063, in patients with osteoarthritis...more >>

Natus Medical reports higher Q2 net income, provides Q3 guidance

Natus Medical Incorporated, a provider of medical devices, has reported that net income for the second quarter ended June 30, 2015 was $9.85 million, or $0.30 per diluted share, compared to $7.46 million, or $0.23 per diluted share, for the same quarter ended June 30, 2014. For the third quarter of 2015, the company expects non-GAAP earnings per share to be in the range of $0.37 to $0.38...more >>

UnitedHealth Group Q2 net earnings increase

UnitedHealth Group Inc., a health care company, has reported that net earnings for the second quarter ended June 30, 2015 were $1.58 billion, or $1.64 per diluted share, compared to $1.41 billion, or $1.42 per diluted share, for the same quarter ended June 30, 2014...more >>

St. Jude reports higher Q2 net earnings, provides Q3 guidance

St. Jude Medical, Inc., a medical device company, has reported that net earnings attributable to the company for the second quarter ended July 4, 2015 were $290 million, or $1.02 per diluted share, compared to $270 million, or $0.93 per diluted share, for the same quarter ended June 28, 2014. For the third quarter of 2015, the company expects consolidated adjusted net earnings to be in the range of $0.96 to $0.98 per share...more >>